Company intelligence / Profile preview

Slopes Bio

Utah, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Slopes Bio operates as a high-complexity CLIA/CAP-accredited laboratory, providing custom assay development, high-throughput sample processing, and advanced bioinformatics to support health and wellness testing at scale. The company has implemented Pleno's RAPTOR platform to enhance the scale and accuracy of polygenic risk scoring, with deployments aimed at processing over 100,000 samples annually and supporting a breadth of partner programs[1][2].

Therapeutic areas: Other
Modalities: Custom assayMulti-omic panelGenomicsProteomics
Industry: Molecular Diagnostics

Partnerships

Pleno

Beyond the preview

Go deeper on Slopes Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slopes Bio.

Explore the full profile